Monthly Archives: August 2018

FDA Grants Eden Spine 510(K) Clearance for Its Thoraco Lumbar Spine Locking Plate – SPHYNX™

GENEVA, SWITZERLAND (PRWEB) AUGUST 30, 2018 The SPHYNX™ is the ideal complement to Eden Spine proprietary, expandable titanium vertebral body replacement implant with rotatable endplates, the GIZA™ which provides multiple angulation options by simple endplates rotation. The GIZA™ is intended to replace and fuse a collapsed, damaged, or unstable vertebral body due to a tumor or

By |2018-08-30T22:53:27+00:00August 30th, 2018|Regulatory, Spine, Top Stories|

K2M Group Holdings, Inc. Announces Definitive Agreement To Be Acquired by Stryker Corporation

LEESBURG, Va., Aug. 30, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body Balance™, today announced a definitive merger agreement with Stryker Corporation ("Stryker", NYSE:SYK) pursuant to which Stryker has agreed to acquire all of

By |2018-08-30T13:33:29+00:00August 30th, 2018|Spine|

Sports Medicine Market USD 9,655.6 Mn Revenue Expected by 2023 | Increasing Awareness on Sports Injury to Drive Bright Future

Pune, India, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Market Research Future® has recently published its Premium Report on Global Sports Medicine Market which reveals that the sports medicine market is projected to grow at a promising CAGR of 8.9% during the forecast period of 2017 to 2023. Sports medicine is a necessary part of the

By |2018-08-29T16:30:28+00:00August 29th, 2018|Sports Medicine|

SeaSpine to Participate in the 13th Annual Wells Fargo Securities Healthcare Conference (corrected time)

CARLSBAD, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the Company plans to participate in the 13th Annual Wells Fargo Securities Healthcare Conference at the Westin Copley Place in Boston, Massachusetts on Wednesday, September

By |2018-08-29T15:42:17+00:00August 29th, 2018|Spine|

Globus Medical to Exhibit Latest Advancements in MIS Spine Surgery at SMISS Annual Forum

AUDUBON, Pa., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will feature its ExcelsiusGPS® revolutionary robotic guidance and navigation system along with its latest advancements in expandable interbody technology at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum being held September 6-8, 2018, in Las Vegas,

By |2018-08-29T15:34:28+00:00August 29th, 2018|Spine|

Nanovis Announces Successful Completion of $5.5 Million Investment Round To Fund Technology-Driven Growth

CARMEL, IND. (PRWEB) AUGUST 28, 2018 Nanovis, an innovative and fast-growing technology company selling nano-technology enhanced spinal implants, announced today the successful completion of a $5.5 million funding round managed by Commenda Securities. Key investors include Elevate Ventures, 1st Source Capital Corporation, Purdue’s Foundry Investment Fund, Commenda Capital, and Ellipsis Ventures. “Our investment in Nanovis is

By |2018-08-28T21:40:45+00:00August 28th, 2018|Financial, Top Stories|

Wright Medical Group N.V. Announces Pricing of Public Offering of Ordinary Shares

AMSTERDAM, The Netherlands, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced the pricing of its previously announced registered underwritten public offering of 18,248,932 of its ordinary shares at an initial price to the public of $24.60 per share.  The net proceeds to Wright from the offering, after deducting the underwriting

By |2018-08-28T17:23:09+00:00August 28th, 2018|Financial|

Ceterix Orthopaedics Announces FDA Clearance of New Suture Cartridge, Providing Increased Flexibility and Enhanced Options for Surgeons

August 28, 2018 FREMONT, Calif.--(BUSINESS WIRE)--Ceterix® Orthopaedics, Inc., a leader in the development of cutting-edge surgical tools for orthopaedic surgeons, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of an added feature to the NovoStitch® Pro Meniscal Repair System – a size 0 suture cartridge – offering surgeons more options to repair meniscal tears.

By |2018-08-28T15:37:59+00:00August 28th, 2018|Regulatory|

SpinalCyte, LLC Announces New U.S. Patent

August 28, 2018 HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts, today announced issuance of U.S. Patent No. 10,052,410, “Methods and Compositions For Repair Of Cartilage Using An In Vivo Bioreactor.” The technology described in the patent involves an in vivobioreactor which acts as a delivery system

By |2018-08-28T15:13:26+00:00August 28th, 2018|Regulatory|

Medicrea to Begin Trading on the OTCQX Market in the U.S.

August 27, 2018 LYON, France & NEW YORK--(BUSINESS WIRE)--The Medicrea Group (Euronext Growth Paris: FR0004178572 - ALMED), pioneering the transformation of spinal surgeries through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI™ technologies, announced today that the Company will begin trading on the OTCQX Best Market under the tickers “MRNTY” and

By |2018-08-27T17:47:19+00:00August 27th, 2018|Financial, Spine|